SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-035403
Filing Date
2022-06-28
Accepted
2022-06-28 09:06:11
Documents
14
Period of Report
2022-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea162137-8k_aikido.htm   iXBRL 8-K 28049
2 PRESS RELEASE, DATED JUNE 28,2022. ea162137ex99-1_aikido.htm EX-99.1 6591
3 GRAPHIC image_001.jpg GRAPHIC 5296
  Complete submission text file 0001213900-22-035403.txt   220922

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20220628.xsd EX-101.SCH 2971
5 XBRL LABEL FILE aiki-20220628_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE aiki-20220628_pre.xml EX-101.PRE 22797
8 EXTRACTED XBRL INSTANCE DOCUMENT ea162137-8k_aikido_htm.xml XML 3773
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 221046690
SIC: 8731 Services-Commercial Physical & Biological Research